Summary:
Psychiatric Care and Research Study are conducting - 401 study and 402 study that are looking at a potential new treatment - an investigational medication - for bipolar depression (bipolar I or bipolar II disorder) to see whether it works, and how safe it is, for improving the symptoms of bipolar depression. The 401 Study will look at the investigational medication when it is used on its own. The 402 Study will look at the investigational medication in patients who are already taking a mood stabilizer, specifically lithium or valproate.
We are looking for people who are currently experiencing major depressive episodes associated with bipolar disorder to take part in the 401 and 402 Studies.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have been diagnosed with bipolar I or bipolar II disorder
•
Be currently having a major depressive episode that started at least 2 weeks ago, but no more than 6 months ago
•
Have previously had a least one bipolar manic episode or mixed episode (if you have bipolar I disorder) or hypomanice episode (if you have bipolar II disorder)
•
Not have substance abuse within 12 months of screening
Qualified Participants May Receive:
Compensation for time and travel may be possible.
Complete psychiatric examination.